Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop.

Area of Science:

• Immunology
• Hematology
• Molecular Biology

Background:

• Lipopolysaccharide (LPS) activates platelets via Toll-like receptor 4 (TLR4), promoting sepsis.
• Platelets are known to process and translate pro-IL-1β RNA but were not known to express IL-1 receptor type 1 (IL-1R1) or respond to IL-1β.

Purpose of the Study:

• To investigate whether platelets express IL-1R1 and respond to IL-1β.
• To elucidate the role of IL-1β in LPS-induced platelet activation and its potential autocrine signaling in platelets.

Main Methods:

• Flow cytometry and Western blotting to detect IL-1R1 expression in platelets.
• Assessment of IL-1β and IL-1α effects on platelet RNA splicing and translation.
• Inhibition studies using IL-1R antagonist, caspase-1 suppression, and protein synthesis blockade.
• In vivo studies in murine carotid artery thrombosis models.

Main Results:

• Platelets express functional IL-1R1 and respond to IL-1β and IL-1α, leading to IL-1β mRNA splicing and translation.
• IL-1β stimulates its own synthesis in platelets via an autocrine loop, associated with shed microparticles.
• IL-1β autocrine signaling is essential for amplifying LPS-induced platelet activation and IL-1β mRNA production.
• Activated platelets produce IL-1β in vivo, observed in occluded murine arteries.

Conclusions:

• IL-1β acts as a novel platelet agonist, promoting its own synthesis through an autocrine loop.
• This IL-1β autocrine loop is critical for amplifying platelet activation by LPS.
• Platelets contribute to thrombosis and immunity by producing IL-1β in response to activation and forming thrombi.